Open Access

Predictors of hospital stay and mortality in dengue virus infection-experience from Aga Khan University Hospital Pakistan

  • Muhammad Abdul Mabood Khalil1Email author,
  • Jackson Tan2,
  • Muhammd Ashhad Ullah Khalil3,
  • Safia Awan1 and
  • Manickam Rangasami4
BMC Research Notes20147:473

https://doi.org/10.1186/1756-0500-7-473

Received: 27 December 2013

Accepted: 15 July 2014

Published: 27 July 2014

Abstract

Background

Dengue virus infection (DVI) is very common infection. There is scarcity of data on factor associated with increased hospital stay and mortality in dengue virus infection (DVI). This study was done to know about factors associated with increased hospital stay and mortality in patients admitted with DVI.

Results

Out of 532 patients, two third (72.6%) had stay ≤3 days while one third (27.4%) had stay greater than 3 days. The mean length of hospital stay was 3.46 ± 3.45 days. Factors associated with increased hospital stay (>3 days) included AKI (acute kidney injury) (Odd ratio 2.98; 95% CI 1.66-5.34), prolonged prothrombin time (Odd ratio 2.03; 95% CI 1.07-3.84), prolonged activated partial thromboplastin time (aPTT) (Odd ratio 1.80; CI 95% 1.15-2.83) and increased age of > 41.10 years (Odd ratio 1.03; CI 95% 1.01-1.04).Mortality was 1.5%. High mortality was found in those with AKI (P <0.01), dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS) (P <0.001), respiratory failure (P0.01), prolong PT (P 0.001), prolong aPTT (P0.01) and increased hospital stay (P0.04).

Conclusion

Increasing age, coagulopathy and acute kidney injury in patients with DVI is associated with increased hospital stay. Morality was more in patients with AKI, DHF and DSS, respiratory failure, coagulopathy and these patients had more prolonged hospitalization.

Keywords

Dengue Predictors of hospital stay Mortality

Background

Dengue virus infection (DVI) is mosquito born disease and is a growing health problem in the world. Due to the advent increase in trade activities and tourism, the virus has been inadvertently transferred from endemic regions to other parts of the world[1, 2]. The number of countries reporting DVI has increased from nine in 1950 to over 100 countries over the past few decades. As a result, over 50 million people are infected by DVI and around 2.5 billion people are at risk[3].

Dengue virus infection causes significant morbidity and mortality. There are four serotypes (DEN 1–4), classified according to biological and immunological criteria. The virus is transmitted by mosquitoes. The clinical manifestations vary in presentation from mild constitutional symptoms to severe infections causing dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). Asymptomatic infections are mild and can be treated as an outpatient. DSS and DHF, on the other hand require admission and treatment in special units equipped with intensive facilities. Dengue was first documented in 1982 in Pakistan[4]. Pakistan had multiple epidemics since the first literature documented epidemic in 1994[5]. The virus is now endemic in all provinces of the country[6, 7]. Recent epidemics in Pakistan had caused significant burden and stress on health care facilities. Dengue is associated with significant morbidity and mortality. Both DSS and DHF have bad expected outcome if not vigilantly picked up and treated. The identification of factors associated with prolong hospital stay and mortality can potentially identify sick patients who can be treated with supportive measures in a special care set up. This in turn can potentially reduce morbidity and mortality. Identification of these risk factors can be incorporated into patient assessment and management protocol to provide better care. To date, there is no literature evidence on length of hospital stay and factors associated with increased hospital stay and mortality. With this in mind, this study was designed to investigate and identify potential factors that may determine length of hospital stay and mortality in patients with DVI.

Methods

Design

This retrospective study was conducted at Aga Khan University Hospital Karachi Pakistan.

Study setting

Aga Khan University Hospital is a tertiary care health facility located in the biggest city in Pakistan. It has 15 inpatient units with a total capacity of 563 beds and is also the tertiary referral center for advance diagnostic procedures and management. Study was conducted at the department of medicine taking care of adult patients.

Study population and sampling

Study subjects included in-patients admitted with a primary diagnosis of DVI and were identified from computerized records from January 2008 to December 2010. Study subjects included patients with age greater than 14 years admitted with the primary diagnosis of DVI and confirmed dengue IgM antibodies confirmed by ELISA, irrespective of severity of DVI. Patients with no laboratory evidence of DVI and those with malaria were excluded. Data on demographics, clinical features, laboratory data, length of stay and mortality were noted on a proforma.

Study tools and data management

Records of the cases were retrieved through codes using international classification of disease (ICD) 9 CM 061 for DVI and international classification of disease (ICD) 9 CM 065.4 for DHF and DSS. Most studies have reported median hospital stay of 3-4 days in patients with DVI[8, 9]. Therefore, we divided the length of hospital stay divided into less than or equal to 3 days and greater than 3 days and these two cohorts were compared for variables that might determine predictors for increased hospital stay. Similar comparisons were done between patients who survived and those who died. WHO 1997 classification was used to classify dengue virus infection into dengue fever (DF), dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS)[10]. We used Acute Kidney Injury Network (AKIN) definition for classification of AKI[11]. AKIN stage 1 AKI was defined as an increase in serum creatinine greater than 26.5 μmole/litre (≥0.3 mg/dl) or 1.5 to 2 fold increase from baseline. AKIN stage 2 AKI was defined as an increase in serum creatinine of greater than 2-3 folds from baseline. AKIN stage 3 AKI was defined as an increase in serum creatinine of greater than 3 fold from baseline or an absolute serum creatinine of greater than 354 μmole/litre (≥4 mg/dl). Mild hepatitis was defined as ALT 45-300 IU/L and severe hepatitis was defined as ALT >300 IU/L.

Ethical consideration

Ethical approval was taken from both departmental and hospital Ethical Review Committee.

Statistical analysis

Descriptive statistics were used to summarize baseline values and demographic data. Quantitative and qualitative data were expressed as mean, median, interquartile range (IQR) and standard deviation (SD) and number of observations with percentage (%) respectively. To evaluate the association between outcomes (length of hospital stay) and each of factors, x2 -test or Fisher’s exact tests of independence were used to compare proportions where appropriate, and the Student’s t-test was used to analyze continuous data. Odds Ratios (OR) and their 95% Confidence Intervals (CI) were estimated using binary logistic regression, with length of hospital stay (≤3 versus >3 days) as outcomes. Multivariable models were constructed, including variables that showed an effect in the prediction of length of hospital stay >3 days in the univariate analysis. All p-values were based on two-sided tests and significance was set at a p-value less than 0.05. The analyses were performed using SPSS (Statistical Package of Social Sciences) version 19.

Results

Of the 532 patients, two thirds (70.9%) were male. The mean age was 35.2 ± 14.7 years (range 15-85 years). Dengue fever was found in majority of the patients (84.4%). DHF and DSS were present only in 76 (14.3%) and 7 (1.3%) patients respectively. All cases of dengue fever, DHF and DSS were dengue IgM antibodies positive by ELIZA. Seventy one (13.3%) patients developed AKI. Mild and severe hepatitis were present in 329 (61.8%) and 47 (8.8%) patients respectively. Prolongation of prothombin time was found in 64 (12%) while 225 (42.3%) patients had prolonged aPTT. Fourteen (2.6%) patients had respiratory failure and 11 (2.1%) patients had neurological involvement (Table 1).
Table 1

Characteristics of the dengue virus infection cases (n = 532)

Variables

Mean ± standard deviation

Median/Range/Percentages

Age, in years

35.29 ± 14.70

32(15-85)

Gender

  

Female

155

29.1%

Male

377

70.9%

Length of hospital stay

3.46 ± 3.45

3(1-33 days); 3[2-4]

Peak creatinine (μmole/litre)

98.124 ± 83.98

79.56(17.68-875.16)

Peak creatinine in AKI (μmole/litre)

229.84 ± 174.15

149.6(114.92-875.16)

Admission creatinine (μmole/litre)

90.16 ± 61.88

79.56(17.68-857.48)

Admission hematocrit (Proportion of 1.0)

0.4102 ± 0.063

0.415(0.199-0.58)

Peak hematocrit (Proportion of 1.0)

0.422 ± 0.0563

0.424(0.264-0.58)

Platelets

38.65 ± 42.14

23(2-427)

Alanine aminotransferase (μkat/L)

2.73 ± 5.86

1.27(0.050-60.55)

Prothrombin time (Seconds)

12.82 ± 8.70

11.10(3-120)

aPTT (Seconds)

36.02 ± 15.12

33.35(11.2-120)

Vasopressin

5

0.9%

Central nervous system involvement

11

2.1%

Respiratory failure

14

2.6%

World Health Organization Classification

  

Dengue fever

449

84.4%

Dengue hemorrhagic fever

76

14.3%

Dengue shock syndrome

7

1.3%

Length of stay in hospital

  

≤3 days

386

72.6%

>3 days

146

27.4%

Alanine aminotransferase

  

Normal

156

29.3%

Mild hepatitis 0.75 - 5.01 μkat/L

329

61.8%

Severe hepatitis >5.01 μkat/L

47

8.8%

Prothrombin time (Seconds)

  

≤15

468

88%

>15

64

12%

Activated partial thromboplastin time (Seconds)

  

≤ 35

307

57.7%

>35

225

42.3%

Platelets (Micro/liter)

  

<50000

406

76.3%

50000-100000

93

17.5%

100000-150000

23

4.3%

>150000

10

1.9%

Number of dengue cases/years

  

2008

76

14.3%

2009

148

27.8%

2010

308

57.9%

The mean hospital stay was 3.46 days ± 3.45; Median 3 [IQR; 2-4]. Three hundred and eighty six patients (72.6%) had a length of stay ≤3 days. One hundred and forty six patients (27.4%) had a length of stay > 3 days. The total numbers of patients with DVI progressively increased from 2008 to 2010 (Table 1). Potential determining factors associated in both groups were analyzed through binary logistic regression analysis. AKI was found an independent predictor for increased length of stay greater than 3 days (Odd ratio 2.98; 95% CI 1.66-5.34). Other independent predictors for increased length of stay greater than 3 days included prolong prothrombin time (PT) (Odd ratio 2.03; 95% CI 1.07-3.84), prolong activated partial thromboplastin time (aPTT) (Odd ratio 1.80; 95% CI 1.15-2.83) and increasing age (Odd ratio 1.03; 95% CI 1.01-1.04) (Table 2). Although univariate analysis showed respiratory failure (P <0.001), neurological involvement (P = 0.04) and hepatitis (P value 0.02) were significant associated with increased hospital stay, however these finding were not reciprocated by multivariate analysis (Table 3).
Table 2

Predictors of mortality

Variable

Univariate analysis

 

Outcome

P value

 

Discharge n = 524

Death n = 8

 

Age, in years

35.0 ± 14.5

49 ± 21.6

0.11

Acute kidney injury

63(12)

8(100)

<0.001

World Health Organization Classification

   

Dengue fever

447(85.3)

2(25)

<0.001

Dengue hemorrhagic fever

73(13.9)

3(37.5)

 

Dengue shock syndrome

4(0.8)

3(37.5)

 

Central nervous system

10(1.9)

1(12.5)

0.15

Diabetes mellitus

45(8.6)

2(25)

0.15

Hypertension

46(8.8)

2(25)

0.15

Respiratory failure

12(2.3)

2(25)

0.01

Prothrombin time (Seconds)

   

<15

465(88.7)

3(37.5)

0.001

>15

59(11.3)

5(62.5)

 

Activated partial thromboplastin time (Seconds)

   

<35

306(58.4)

1(12.5)

0.01

>35

218(41.6)

7(87.5)

 

Platelets (Micro/litre)

   

<150

514(98.1)

8(100)

0.99

>150

10(1.9)

0

 

Length of stay

3.3 ± 3.2

10.6 ± 8.4

0.04

Median [IQR]

3[2-4]

10[2-17.75]

 
Table 3

Predictors of length of hospital stay in individuals aged ≥ 14 years hospitalized for dengue virus infection (n = 532)

Variable

Univariate analysis

Multivariate analysis

 

Length of stay in hospital

P value

Odd ratio [95% CI]

P value

 

≤ 3 days n = 386

>3 days n = 146

   

Age, in years

33.10 ± 13

41.10 ± 17.20

<0.001

1.03[1.01-1.04]

<0.001

Acute kidney injury

29(7.5)

42(28.8)

<0.001

2.98[1.66-5.34]

<0.001

World Health Organization Classification

     

Dengue fever

329(85.2)

120(82.2)

0.002

1.0

 

Dengue hemorrhagic fever

56(14.5)

20(13.7)

 

0.91[0.49-1.69]

0.76

Dengue shock syndrome

1(0.3)

6(4.1)

 

2.37[0.23-24.2]

0.46

Central nervous system

5(1.3)

6(4.1)

0.04

0.79[0.17-3.6]

0.76

Diabetes mellitus

28(7.3)

19(13)

0.03

0.84[0.38-1.87]

0.68

Hypertension

26(6.7)

22(15.1)

0.003

1.13[0.50-2.51]

0.76

Respiratory failure

4(1)

10(6.8)

<0.001

3.2[0.76-13.3]

0.11

Alanine aminotransferase

     

Normal

110(28.5)

46(31.5)

0.02

  

Mild hepatitis

249(64.5)

80(54.8)

   

Severe hepatitis

27(7)

20(13.7)

   

Prothrombin time (Seconds)

     

≤ 15

353(91.5)

115(78.8)

<0.001

  

> 15

33(8.5)

31(21.2)

 

2.03[1.07-3.84]

0.02

Activated partial thromboplastin time (Seconds)

     

≤ 35

243(63)

64(43.8)

<0.001

  

>35

143(37)

82(56.2)

 

1.80[1.15-2.83]

0.01

Platelets (Micro/litre)

     

<50000

295(76.4)

111(76)

0.12

1.0

 

50000-100000

70(18.1)

23(15.8)

 

0.23[0.04-1.13]

0.07

100000-150000

17(4.4)

6(4.1)

 

0.31[0.03-1.1]

0.11

>150000

4(1)

6(4.1)

 

0.36[0.06-1.88]

0.22

Death

2(0.5)

6(4.1)

0.002

0.86[0.13-5.4]

0.87

Mean hospital stay was 10.63 ± 8.434 days in those who died. High mortality (n = 8; 1.5%) was found in those with AKI (P <0.01), dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS) (P <0.001), respiratory failure (P0.01), prolong PT (P 0.001), prolong aPTT (P0.01) and increased hospital stay (P0.04) (Table 2).

Discussion

Dengue and DHF have emerged as some of the most important mosquito-borne viral diseases. After multiple epidemics of DVI, dengue is now endemic in all provinces of Pakistan and it is in fact a growing public health problem in Pakistan. Our patient demographics are not dissimilar to other DVI patients reported in the literature. Like other South Asian studies, there is a male preponderance for DVI. Studies from India and Singapore reported male to female ratio of 1.9: 1and 1:0.57 respectively[7, 12]. This may be because men are more likely to have better access to healthcare in our society compared to women who are less likely to be taken for care at a hospital when ill. Secondly males may be more exposed to mosquito bites from outdoor sources due to their increased outside home activities.

Regarding length of hospital stay, “one third” of patients with DVI had a prolonged hospital stay. The mean hospital stay reported in our study was 3.46 days. Various studies done at national and international level reported a mean stay of 3.4-6.2 days which are comparable to our results[79, 12]. We specifically concentrated on this latter group of patients who had a prolonged stay at hospital of greater than 3 days. Presence of AKI, increasing age and coagulopathy were associated with increased hospital stay.

AKI was present in 13.3% patients admitted with DVI. AKI in DF results from hypoperfusion and hypoxia from shock[13]. Various studies showed incidence of AKI in 0.9% to 10.8%[1315] in patients with DVI and associated with increased mortality[15]. We found the presence of AKI associated with prolonged stay in hospital in patients with dengue virus infection.

Significant number of our study patients showed coagulopathy manifested by abnormality of both extrinsic and intrinsic pathway in patients with DVI. Coagulopathy is now a well-established fact[16, 17]. Coagulopathy is multifactorial and may be due to low platelets, deranged PT, aPTT and hepatitis. In addition to AKI we found coagulopathy and increasing age as important predictors associated with increased hospital stay. Although we found hepatitis and thrombocytopenia in a significant number of patients but neither of these had an impact on hospital stay. The mortality rate from our study was 1.5%. Various studies from Pakistan have reported mortality of 2.6%-2.7% in general population infected with DVI[18, 19]. International data reports a variable mortality ranging from 0-3.7%[2023]. However it was interesting to note that all those patients who died had AKI. Similarly mortality was more in those who had a prolong hospital stay, respiratory failure, DHF and DSS, and coagulopathy. However the number of patients died in our cohort was very small (n = 8) to compare with those who survived. Therefore, larger cohorts are needed to study various factors associated with mortality.

Increasing age in combination with AKI and coagulopathy might denote seriously sick patients who can potentially have more morbidity in the form of increased hospital stay. These patients also had more propensity to die. AKI might be due to vascular leakage and coagulopathy in patients with DVI. Therefore the combination of AKI, coagulopathy with increasing age in patients with DVI might put them at risk to develop ischemia of various organs resulting in increased hospital stay. Therefore, these patients should be identified at the earliest and treated preferably in a special care set up to avoid morbidity and mortality. To the best of our knowledge, these factors have never been formally implicated in the literature in increasing hospital stay. The presence of these factors in severely ill patients may have necessitated the use of advanced therapies like renal replacement therapy or ventilator support which would have delayed hospital discharge. These patients were also more likely to have co-existing haemodynamic disturbances and bacterial septicaemia which would have required treatment with inotropes and antibiotics. Furthermore, older patients would have other co-morbidities and have rehabilitational issues which may complicate admissions and extend hospital stay.

We acknowledge that there are several limitations in this study. The retrospective nature of data collection may have biased the findings towards patients who are more unwell and hence more likely to be captured and recorded by the system. We would have liked to grade DHF if the study is done prospectively as it would have enabled us to diagnose early DHF which may have been undetected and unrecorded by our coders. We also acknowledge that criteria for admission and discharges may have been variable among various clinicians taking care of these patients and could interfere with the results of our findings. To asses factors associated with mortality more larger cohort of patients is needed. Moreover, the study population included adults patients and hence its results cannot be generalized to pediatric patients. The study is also limited to one center and may not be representative of the population as a whole.

Conclusion

Acute kidney injury, coagulopathy and increase age are associated with prolonged hospital stay. Mortality is commoner in those with AKI and prolonged hospital stay. With these in mind we advise extra vigilance and cautionary strategies when encountering DVI patients with these risk factors. More studies are needed to investigate preventive strategies on minimizing the occurrences of these potential deleterious factors.

Abbreviations

DVI: 

Dengue virus infection

DHF: 

Dengue hemorrhagic fever

DSS: 

Dengue shock syndrome

PT: 

Prothrombin time

aPTT: 

Activated partial thromboplastin time

AKI: 

Acute kidney injury.

Declarations

Acknowledgment

We acknowledge Dr. Muhammad Tariq Head of Department of Medicine, for his support in collection of data and his guidance. We also acknowledge Mr. Ghulam Rasool for typing this manuscript.

Authors’ Affiliations

(1)
Department of Medicine, Aga Khan University Hospital
(2)
Department of Nephrology RIPAS Hospital
(3)
Department of Medicine Khyber Teaching Hospital
(4)
Department of Nephrology SSB Hospital

References

  1. O'Brien D, Tobin S, Brown GV, Torresi J: Fever in returned travelers: review of hospital admissions for a 3-year period. Clin Infect Dis. 2001, 33: 603-609. 10.1086/322602.PubMedView ArticleGoogle Scholar
  2. MacLean J, Lalonde R, Ward B: Fever from the tropics. Travel Med Advisor. 1994, 5: 27.1-27.14Google Scholar
  3. Muto R: Summary of dengue situation in WHO Western Pacific Region. Dengue Bulletin. 1998, 22: 12-19.Google Scholar
  4. Hayes CG, Baqar S, Ahmed T, Chandhury MA, Reisen WK: West Nile virus in Pakistan. 1. Sero-epidemiological studies in Punjab Province. Trans R Soc Trop Med Hyg. 1982, 76: 431-436. 10.1016/0035-9203(82)90130-4.PubMedView ArticleGoogle Scholar
  5. Chan YC, Salahuddin NI, Khan J, Tan HC, Seah CL, Li J, Chow VT: Dengue haemorrhagic fever outbreak in Karachi, Pakistan. Trans R Soc Trop Med Hyg. 1994, 89 (6): 619-620.View ArticleGoogle Scholar
  6. Ahsan T: Dengue fever: a regular epidemic?. J Pak Med Assoc. 2008, 58: 1-2.PubMedGoogle Scholar
  7. Goh KT, Ng SK, Chan YC, Lim SJ, Chua EC: Epidemiological aspects of an outbreak of dengue fever/dengue haemorrhagic fever in Singapore. Southeast Asian J Trop Public Health Med. 1987, 18: 295-302.Google Scholar
  8. Khan NA, Azhar EI, El-Fiky S, Madani HH, Abuljadail MA, Ashishi AM, Turkistani AM, Hamouh EA: Cinical profile and outcome of hospitalized patients during first outbreak of dengue in Makkah, Saudi Arabia. Acta Trop. 2008, 105: 39-44. 10.1016/j.actatropica.2007.09.005.PubMedView ArticleGoogle Scholar
  9. Lye D, Chan M, Lee V, Leo YS: Do young adults with uncomplicated dengue fever need hospitalisation? A retrospective analysis of clinical and laboratory features. Singapore Med J. 2008, 49: 476-479.PubMedGoogle Scholar
  10. Dengue hemorrhagic fever: diagnosis, treatment, prevention and control. 1997, Geneva: WHOGoogle Scholar
  11. Mehta RL, Kellum JA, Shah SV, Molitoria BA, Ronco C, Warnock DG, Levin A: Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Car. 2007, 11: R31-10.1186/cc5713.View ArticleGoogle Scholar
  12. Agarwal R, Kapoor S, Nagar R, Misra A, Tandon R, Malhur A, Misra AK, Srivastava KL, Chaturvedi UC: A clinical study of the patients with dengue hemorrhagic fever during the epidemic of 1996 at Lucknow, India. Southeast Asian J Trop Med Public Health. 1999, 30: 735-740.PubMedGoogle Scholar
  13. Laoprasopwattana K, Pruekprasert P, Dissaneewate P, Greater TA, Vachvanichsanong P: Outcome of dengue hemorrhagic fever-caused acute kidney injury in Thai children. J Pediatr. 2010, 157: 303-309. 10.1016/j.jpeds.2010.02.008.PubMedView ArticleGoogle Scholar
  14. Lee IK, Liu JW, Yang KD: Clinical characteristics, risk factors, and outcomes in Adults experiencing dengue hemorrhagic fever complicated with acute renal failure. Am J Trop Med Hyg. 2009, 80: 651-655.PubMedGoogle Scholar
  15. Mehra N, Patel A, Abraham G, Reddy YN: Acute kidney injury in dengue fever using Acute Kidney Injury Network criteria: incidence and risk factors. Trop Doct. 2012, 42: 160-162. 10.1258/td.2012.120023.PubMedView ArticleGoogle Scholar
  16. Huerta-Zepeda A, Cabello-Gutiérrez C, Cime-Castillo J, Monroy-Martínez V, Manjarr Zavala ME, Gutiérrez-Rodríguez M: Crosstalk between coagulation and inflammation during Dengue virus infection. Thromb Haemost. 2008, 99: 936-943.PubMedGoogle Scholar
  17. Mairuhu AT, Mac Gillavry MR, Setiati TE, Soemantri A, Ten Cate H, Brandjes DP, Van Gorp EC: Is clinical outcome of dengue-virus infections influenced by coagulation and fibrinolysis? A critical review of the evidence. Lancet Infect Dis. 2003, 3: 33-41. 10.1016/S1473-3099(03)00487-0.PubMedView ArticleGoogle Scholar
  18. Parkash O, Almas A, Jafri SM, Hamid S, Akhter J, Alishah H: Severity of acute hepatitis and its outcome in patients with dengue fever in a tertiary care hospital Karachi, Pakistan (South Asia). BMC Gastroenterol. 2010, 10: 43-10.1186/1471-230X-10-43.PubMedPubMed CentralView ArticleGoogle Scholar
  19. Wasay M, Channa R, Jumani M, Zafar A: Changing patterns and outcome of Dengue infection; report from a tertiary care hospital in Pakistan. J Pak Med Assoc. 2008, 58: 488-489.PubMedGoogle Scholar
  20. Seet R, Ooi EE, Wong HB, Paton NI: An outbreak of primary dengue infection among migrant Chinese workers in Singapore characterized by prominent gastrointestinal symptoms and a high proportion of symptomatic cases. J Clin Virol. 2005, 33: 336-340. 10.1016/j.jcv.2005.03.002.PubMedView ArticleGoogle Scholar
  21. Gonzalez D, Castro OE, Kouri G, Perez J, Martinez E, Vazquez S, Rosario P, Cancio R, Guzman MG: Classical dengue hemorrhagic fever resulting from two dengue infections spaced 20 years or more apart: Havana, Dengue 3 epidemic,2001-2002. Int J Infect Dis. 2005, 9: 280-285. 10.1016/j.ijid.2004.07.012.PubMedView ArticleGoogle Scholar
  22. Wichmann O, Hongsiriwon S, Bowonwatanuwong C, Chotivanich K, Sukthana Y, Pukrittayakamee S: Risk factors and Clinical features associated with severe dengue infection in adults and children during the 2001 epidemic in Chonburi, Thailand. Trop Med Int Health. 2004, 9: 1022-1029. 10.1111/j.1365-3156.2004.01295.x.PubMedView ArticleGoogle Scholar
  23. Harris E, Videa E, Pérez L, Sandoval E, Llez Y, Pérez MA, Cuadra R, Rocha J, Idiaquez W, Alonso R, Delgado MA, Campo L, Acevedo F, Gonzalez A, Amador J, Balmaseda A: Clinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in Nicaragua. Am J Trop Med Hyg. 2000, 63: 5-11.PubMedGoogle Scholar

Copyright

© Khalil et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement